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Abstract  
Background 
To study the role of African buffalos (Syncerus caffer) in the maintenance of foot-
and-mouth disease in Uganda, serum samples were collected from 207 African 
buffalos, 21 impalas (Aepyceros melampus), 1 giraffe (Giraffa camelopardalis), 1 
common eland (Taurotragus oryx), 7 hartebeests (Alcelaphus buselaphus) and 5 
waterbucks (Kobus ellipsiprymnus) from four major National Parks in Uganda 
between 2005 and 2008. Serum samples were screened to detect antibodies against 
foot-and-mouth disease virus (FMDV) non-structural proteins (NSP) using the 
Ceditest® FMDV NS ELISA. Solid Phase Blocking ELISAs (SPBE) were used to 
determine the serotype-specificity of antibodies against the seven serotypes of FMDV 
among the positive samples. Virus isolation and sequencing were undertaken to 
identify circulating viruses and determine relatedness between them. 
Results 
Among the buffalo samples tested, 85% (95% CI = 80−90%) were positive for 
antibodies against FMDV non-structural proteins while one hartebeest sample out of 
seven (14.3%; 95% CI = −11.6−40.2%) was the only positive from 35 other wildlife 
samples from a variety of different species. In the buffalo, high serotype-specific 
antibody titres (≥ 80) were found against serotypes O (7/27 samples), SAT 1 (23/29 
samples), SAT 2 (18/32 samples) and SAT 3 (16/30 samples). Among the samples 
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titrated for antibodies against the four serotypes O, SAT 1, SAT 2 and SAT 3, 17/22 
(77%; CI = 59.4−94.6%) had high titres against at least two serotypes.  
FMDV isolates of serotypes SAT 1 (1 sample) and SAT 2 (2 samples) were obtained 
from buffalo probang samples collected in Queen Elizabeth National Park (QENP) in 
2007. Sequence analysis and comparison of VP1 coding sequences showed that the 
SAT 1 isolate belonged to topotype IV while the SAT 2 isolates belonged to different 
lineages within the East African topotype X.  
Conclusions 
Consistent detection of high antibody titres in buffalos supports the view that African 
buffalos play an important role in the maintenance of FMDV infection within 
National Parks in Uganda. Both SAT 1 and SAT 2 viruses were isolated, and 
serological data indicate that it is also likely that FMDV serotypes O and SAT 3 may 
be present in the buffalo population. Detailed studies should be undertaken to define 
further the role of wildlife in the epidemiology of FMDV in East Africa. 
Background  
Foot-and-mouth disease (FMD) is a highly contagious viral disease that affects all 
cloven-hoofed wild and domestic animals [1] and has serious socio-economic 
consequences [2]. The epidemiology of FMD in Africa is unique, complex and poorly 
understood. Seven FMDV serotypes have been defined: O, A, C, Asia 1, and the 
Southern African Territories (SAT) 1, SAT 2 and SAT 3, of which all but Asia 1 have 
occurred in most East African countries including Uganda [3]. Wildlife hosts, 
especially African buffalos (Syncerus caffer), are believed to play an important role as 
reservoirs for the SAT serotypes of FMDV [4] and the disease is sometimes 
transmitted between and within different livestock and wildlife species [5−9]. 
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In Africa, the epidemiology of FMD is complicated by the widespread movement of 
animals, the wide host range of the virus involving wild and domestic animal 
reservoirs and the presence of multiple strains and sub-strains. Moreover, the spread 
of the disease is facilitated by the ability of the virus to survive for relatively long 
periods in raw meat, raw milk or outside the host [1, 10, 11]. Infection of cloven-
hoofed animals can result in development of a carrier state in which case FMDV may 
be found in such animals for more than 28 days after infection [12−14], and thus may 
influence the epidemiology of the disease and interfere with its diagnosis and control. 
The duration of the carrier state can be prolonged after recovery from acute disease; in 
the case of cattle for up to 3.5 years [14]. The epidemiology of FMD in wildlife 
populations has not been fully documented but it has been established that African 
buffalo herds can harbour the infection for up to 24 years [15]. They act as long term 
maintenance hosts for the SAT serotypes (SAT 1, SAT 2 and SAT 3) of FMDV with 
no obvious clinical disease [4, 16]. Other cloven-hoofed wildlife species may develop 
antibodies against FMD infections; however, their roles in excretion, transmission and 
persistence of FMDV either have not been conclusively studied or have been shown 
to be less important than the role of the buffalos [7, 17, 18]. In South Africa, the 
impala (Aepyceros melampus) has been shown to play a potentially significant role in 
the propagation of FMD outbreaks between livestock and wildlife [19]. 
FMD outbreaks are often encountered in cattle in Uganda but the roles of different 
wild and domestic hosts in the maintenance and spread of FMDV have not been 
exhaustively studied. Available data on seventy-three Ugandan FMD outbreaks, 
mainly in cattle, and a few isolates from apparently healthy buffalos, indicate that 
between the years 1958 and 2000, approximately 31% were attributed to serotype O, 
26% to A, 25% to SAT 2, 14% to SAT 1, 3% to C and 1% to SAT 3 [3]. FMDV 
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serotypes SAT 1, SAT 2 and SAT 3 have been found in many other sub-Saharan 
African countries, however, the viruses found in East Africa seem to belong to 
distinct lineages [20, 21, 22]. The possible role played by the African buffalos in the 
epidemiology of FMDV serotypes other than SATs has not been established, since 
only one single study in Queen Elizabeth National Park has reported antibodies 
against serotypes O and A [23], thus further research is required in this field.  
This study was undertaken to evaluate the role of African buffalos and other wildlife 
species in the maintenance of different FMDV serotypes under natural conditions in 
selected National Parks in Uganda.  
Results  
Antibodies elicited against FMDV NSP 
Between 2005 and 2008, 207 samples were collected from African buffalos and 35 
samples were collected from other wildlife species (21 impala (Aepyceros melampus), 
1 giraffe (Giraffa camelopardalis), 1 common eland (Taurotragus oryx), 7 hartebeest 
(Alcelaphus buselaphus) and 5 waterbuck, (Kobus ellipsiprymnus)) in Queen 
Elizabeth National Park (QENP), Lake Mburo National Park (LMNP), Kidepo Valley 
National Park (KVNP) and Murchison Falls National Park (MFNP). One hundred and 
seventy-six out of 207 buffalo samples (85%; 95% CI = 80−90%) tested positive for 
antibodies against FMDV NSP (Table 1), while only one of seven hartebeest samples 
(14.3%; 95% CI = −11.6−40.2%) from among those of other wildlife species tested 
positive in the NSP ELISA.  
Screening for serotype-specific antibodies using the Solid Phase Blocking ELISA 
(SPBE) 
Ninety-six percent (131/137) of the buffalo samples tested were apparently positive 
for antibodies against more than one serotype in the screening dilution 1:5 in SPBE. 
The proportion of positive samples was higher for serotypes SAT 1, SAT 2, SAT 3 
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and to a lesser extent serotype O, than for serotypes A, C and Asia 1. One hartebeest 
tested positive for SAT 1, SAT 2, and SAT 3 (data not shown). Cross reactivity 
between the different serotypes is known to occur in such assays [17]. 
Titration of selected samples in relevant serotype-specific SPBEs  
Samples from QENP, MFNP and LMNP were selected for titration on the basis of 
positive screening results and sufficient volumes with the objective of comparison of 
results across multiple years. A total of 37 buffalo samples were titrated in the 
relevant serotype-specific SPBEs as follows; O (27), SAT 1 (29), SAT 2 (32) and 
SAT 3 (30) as shown in Table 2. In this study, samples with titres of ≥ 80 were 
considered positive based on the highest dilution at which non-specific reactions 
tended to disappear and the results of a previous study [24]. All the sera titrated for 
antibodies against serotypes A, C and Asia 1 had titres below 40 and were therefore 
considered negative (data not shown), while titres of 80 and above were found in the 
majority of sera titrated for antibodies against serotypes O (26%; 95% CI = 
9.5−42.6%), SAT 1 (79%; 95% CI = 64.6−94.1%), SAT 2 (56%; 95% CI = 
39.1−73.4%) and SAT 3 (53%; 95% CI = 35.45−71.2%). The samples positive for 
antibodies against FMDV serotype O were also positive for at least two of the SAT 
serotypes. Six of 22 (27%; 95% CI = 8.7−45.9%) samples titrated for antibodies 
against all three SAT serotypes as well as against serotype O were positive for all four 
serotypes, while 17 (77%; 95% CI = 59.5−94.6%) were positive for at least two 
serotypes. Nine of the 24 samples titrated for antibodies against all three SAT 
serotypes were positive for antibodies against all 3 serotypes, including at least one 
buffalo in each of QENP, LMNP and MFNP. 
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Isolation and identification of FMDV  
Three FMDV isolates were obtained in primary bovine thyroid cells from among nine 
buffalo probang samples collected on the same day in January 2007 in QENP, and 
were identified by antigen ELISA as SAT 1 (1 sample from BUF 17) and SAT 2 
(from BUF 6 and BUF 10). BUF 17 had a higher titre of antibodies against SAT 1 
(160) compared to those against SAT 2 (80) and SAT 3 (20) (Table 2), while the sera 
of BUF 6 and BUF 10 were not titrated in the SPBE. Following RT-PCR, the near 
complete genome sequences were obtained and blasted in the GenBank data base. The 
sequencing data was entirely consistent with the antigen ELISA results in terms of 
serotype identification. Due to the limited number of full length SAT serotype 
sequences that are available, comparative analysis of the virus sequences was 
restricted to the VP1 coding region. These sequences were compared to reference 
strains for the defined topotypes [25] to assess the phylogenetic relationships (Figures 
1 and 2). The SAT 1 isolate (SAT 1/UGA/1/07, [GenBank HM067706]) was most 
closely related (pair wise identity of 83%) to a previous isolate obtained from a 
buffalo in Uganda in 1970 (SAT 1/UGA BUFF/21/70, Knowles et al., unpublished) 
belonging to the East African topotype IV (Figure 1). The two SAT 2 isolates were 
closely related to each other (pair wise identity of 90.4%) and grouped with 
representatives of the topotype X viruses (Figure 2). One of the isolates, SAT 
2/UGA/1/07 [GenBank HM067705], was also related to an isolate from cattle in the 
neighbouring country of Democratic Republic of Congo (pair wise identity 89.5%), 
while the other, SAT 2/UGA/2/07 [GenBank HM067704], was related to a previous 
isolate from a buffalo in Uganda (SAT 2/UGA/1998, accession number AY343969) 
with pair wise identity of 89.6%. There were multiple amino acid differences between 
the SAT 2 viruses within the G-H loop (residues 140−160) and the C-terminal region 
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of VP1 which correspond to known antigenic sites (Figure 3). The recent SAT 2 
buffalo isolates had some amino acid differences, within the hyper-variable regions 
surrounding the conserved RGD cell attachment motifs, compared to  those obtained 
from post-outbreak slaughtered cattle in Uganda in 2004 [26].  
Discussion  
Antibodies against FMDV were detected by both the Ceditest® FMDV NS kit and the 
SPBE in over 80% of screened buffalo samples. Among the samples of wildlife 
species other than the buffalos, it was only one from a hartebeest that had detectable 
antibodies against FMDV. Due to small sample sizes in other tested wildlife species, 
it is, at this stage, not possible to explain or conclude anything about the importance 
of these other species relative to buffalos. However, the findings of this study do 
relate to those of other studies done elsewhere. It has been indicated that a number of 
wild ruminants become persistently infected with FMDV but it is only the African 
buffalos that have been shown to spread the infection during the carrier state [16, 27]. 
The situation seems to be different within the impala population in the Kruger 
National Park in South Africa, where clinical FMD has been reported, and subclinical 
infections have been shown to occur much more regularly than previously suspected 
[19]. It is hypothesized that during the acute state of the disease some species may act 
as intermediaries in the transmission of FMD, mainly between buffalos and cattle [6, 
18, 19]. The current findings concur with reports of very low seroprevalence of 
antibodies against FMDV in non-buffalo wildlife species (4.4%) compared to buffalos 
(67.7%) in Eastern Africa [17]. The Ceditest® NSP ELISA seemed to work well in 
detecting antibodies against FMDV in buffalo samples, with estimates of sensitivity 
and specificity at 87.7% and 87.3%, respectively [17].  
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In this study, the majority of the buffalos were positive for antibodies against FMDV 
NSP during each of the sampling trips between the years 2005 and 2008. This 
indicates that infection is almost always present in the sampled National Parks. 
Persistent infections within buffalo herds have been reported to occur in Southern 
Africa due to most calves becoming infected with the three SAT serotypes, when 
maternal antibodies wane at 2-6 months of age, thereby creating an opportunity for 
transmitting the infection to other susceptible species [28−30]. The current findings 
justify the need to conduct much more in-depth age-stratified longitudinal studies to 
confirm the serotypes and patterns of FMD in different localities in Uganda.  
SPBE screening results (dilution 1:5) were difficult to interpret due to the large 
percentage (96%) of animals apparently testing positive for antibodies against more 
than one serotype. However, titrations showed that reactions in the serotype A, C and 
Asia 1 antibody ELISAs were most likely cross-reactions. This fits well with the lack 
of any reports of such serotypes in wildlife in Uganda, the almost complete 
disappearance of serotype C from the world and the fact that serotype Asia 1 has 
never been reported anywhere on the African continent [3].  
This is the first time the SPBEs have been used in an unvaccinated animal population 
like the buffalos, which probably harbour persistent infections with multiple 
serotypes. For future studies in endemic conditions, sera should be screened in 
dilution 1:10, and the SPBE ELISAs should be improved by using more purified 
antigens and more recent FMDV strains representing the FMDV topotypes currently 
circulating in Uganda for the production of reagents and positive sera, thereby 
possibly enhancing the specificity. 
Screening of samples by serotype-specific SPBE worked well for selection for further 
titration, thereby significantly reducing the associated working time and expense. 
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Titrations demonstrated the highest antibody titres against serotypes SAT 1, SAT 2 
and SAT 3 with the exception of one out of four buffalos sampled in MFNP in 2007 
that had equally high titres against serotypes O and SAT 1.  
It is thus evident from the present study, that buffalos were exposed to the FMDV 
SAT serotypes, and in MFNP probably also to serotype O. These findings suggest that 
African buffalos may play an important role as natural reservoirs of the SAT 
serotypes of FMDV in East Africa and are consistent with what has been established 
in Southern Africa [31−33]. Detection of antibodies against serotype O in this study 
confirms previous reports of antibodies against other FMDV serotypes than the SATs 
in buffalos in QENP [23].  
The distribution of serotypes varied between the National Parks and between 
sampling trips. In this study, a large proportion of the buffalo samples had high 
antibody titres against more than one serotype of FMDV (77%), and this is consistent 
with previous research findings [17, 23, 24]. The relative antibody prevalences found 
in this study (SAT 1 > SAT 2 > SAT 3 > O) differ from those of Bronsvoort et al. 
[17], who found that antibodies against SAT 2 were the most prevalent, followed by 
SAT 1 and finally SAT 3, in African buffalos in Eastern Africa. This is likely due to 
spatial and temporal differences in the distribution of the infection.  
Three FMDV isolates consisting of one SAT 1 from a buffalo in one herd and two 
SAT 2 from buffalos in another herd were obtained from three out of nine African 
buffalo probang samples collected on the same day in 2007 in QENP indicating the 
presence of either current or persistent infection. The three isolates were characterised 
using antigen ELISA and by full-length sequencing. The VP1 coding regions of the 
two SAT 2 isolates showed that these viruses belonged to the same topotype (X) but 
different lineages, with 90.4% pair wise identity. One of the SAT 2 isolates (SAT 
 - 11 - 
2/UGA/1/07) was most closely related with a previous isolate (SAT 2/ZAI/1/82 
[AF367100]) from cattle in the neighbouring country of Democratic Republic of 
Congo (89.5% pair wise identity) indicating a possibility of cross-border and wildlife-
livestock transmission. The SAT 1 sequence was closest to a representative of the 
topotype IV isolate obtained in 1970 from a buffalo in Uganda (SAT 1/UGA 
BUFF/21/70, N. Knowles, unpublished) with a pair wise identity of 83%. It is clear 
from this study that the viruses obtained are different from each other. These 
differences may be of particular significance during selection of strains that may be 
considered for vaccine manufacture and effective control of foot-and-mouth disease 
due to a range of viruses that may be shared between wildlife and livestock. The 
isolation and characterization of these viruses from buffalo confirms the presence of 
SAT 1 and SAT 2 types of FMDV as demonstrated serologically by SPBEs. More 
molecular epidemiological studies are necessary for precise elucidation of the 
diversity of FMDV genotypes and the possible challenges involved in matching such 
strains with those included in vaccines produced for use in Uganda. Molecular studies 
including the current SAT 1 virus in this study suggest that a unique group of SAT 1 
viruses exist in Uganda and, may necessitate a regional approach for effective control 
[34]. 
Consistent evidence of antibodies against multiple serotypes of FMDV in several 
Ugandan National Parks and the isolation of SAT 1 and SAT 2 in QENP in 30% of 
nine apparently healthy buffalos indicates that wildlife maintains FMDV infections, 
and thus re-affirms recent findings in buffalo sera collected during 2001−2003 [34]. 
These findings combined with serological evidence of exposure of cattle grazing in 
QENP to the SAT serotypes [35] emphasizes the need to study FMDV isolates from 
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these two populations to establish whether FMDV is transferred between them and at 
which rate.  
FMDV serotype SAT 3 was isolated from a buffalo in QENP in 1970 [36] and this 
study indicates that this serotype may still be present. It is not clear why outbreaks 
caused by serotype SAT 3 have never been confirmed in cattle, while outbreaks of 
FMDV SAT 1 and SAT 2 are quite frequent in the region.  
The findings of this study highlight the challenges involved in the diagnosis and 
control of FMD in endemic areas and emphasize the need for optimization of the 
methods used for serological diagnosis and for serotyping of FMDV outbreaks. There 
is need for more studies to investigate detailed epidemiology of FMD in wildlife in 
Uganda. 
  
Conclusions  
African buffalos are important for the maintenance of FMDV within National Parks 
of Uganda. They play an important epidemiological role in the circulation of FMDV 
serotypes SAT 1 and SAT 2, and may also harbour serotype SAT 3 and O infections.  
Methods 
Study area 
The present study was kindly approved by Uganda Wildlife Authority 
(UWA/PMR/RES/50) and wildlife samples were collected from four major National 
Parks in Uganda, namely; QENP, LMNP, MFNP and KVNP (Figure 4). These 
National Parks were chosen on the basis of the high chance of livestock-wildlife 
interactions. Compared to other National Parks in Uganda, they are generally flat or 
gently sloping and not densely covered by vegetation thereby facilitating the exercise 
of darting and follow up of the sedated animals. Such National Parks are also home to 
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sizeable buffalo populations with estimates of about 6,807 animals in QENP, 132 in 
LMNP, 8,200 in MFNP and 400 in KVNP [37]. All the national parks are unfenced 
and hence provide possibilities for livestock-wildlife interactions.  
Due to the large buffalo population and the very high chances of livestock-wildlife 
interactions, more samples were collected in QENP than in the other parks. 
Sampling 
Apart from the impala, chemical capture was used for immobilization of animals of 
choice [38, 39]. The original target of sampling at least 10% of each herd was not 
possible. Most buffalo herds would disperse and sometimes scatter to inaccessible 
areas upon darting one or a few of them. At times it would be impossible to locate 
herds in the National Parks. Animals were darted with a Dan-Inject dart gun. Two 
cars were used; one for the identifying and darting the animals and the other for 
tracking the herds, general field support and tracing the darted animal. Buffalo herds 
were located and animals moving at the edge of the group identified and darted. The 
anaesthetic combination was 8-10mg Etorphine (Kyron, South Africa) and 70-90mg 
Xylazine (Kyron, South Africa). The sedated animal would be cautiously located and 
approached, held by the horns and head, blindfolded and the mouth opened and the 
tongue pulled out for examination for lesions and ensuring continuous respiration 
before collection of serum and probang samples. After sampling, the sedative was 
reversed by use of a combination of 14-18mg Diprenorphine and 60-70mg Yohimbine 
(Kyron, South Africa) by intravenous infusion through the ear vein. The age of the 
buffalos was estimated from the teeth. All buffalos fell within the age group used for 
rinderpest serosurveillance (1.8-20 years). Non-buffalo species other than the impala 
were also darted following similar techniques as defined by Kock et al. [39]. Due to 
significant challenges of chemical capture, impala were instead physically restrained 
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after dazzling them with strong light directed at the eyes at night time, during periods 
of little or no moonlight [40].  
 A total of 134 African buffalo samples and 21 impala samples were collected during 
16 trips in the years 2007 and 2008 (Table 1). The samples from giraffe (1), 
hartebeest (7) and waterbuck (5), were jointly obtained through the on-going wildlife 
health research and monitoring programmes by Uganda Wildlife Authority in 2007. 
Eighty African buffalo samples and 1 Eland sample had been collected during the 
rinderpest serosurveillance exercise between the years 2005 and 2006. Probang 
samples were preserved in 0.04 M phosphate buffered saline (PBS), transported under 
liquid nitrogen while in the field and stored at -80°C at the laboratory. Serum was 
separated from blood and stored at -20°C in the laboratory. 
Screening for antibodies to FMDV non-structural proteins 
207 buffalo samples were screened for antibodies against non-structural proteins 
(NSP) of FMDV using the commercial Ceditest FMDV NS® kit (Cedi diagnostics 
BV, Netherlands) [41]. This test is currently marketed as Priocheck® FMDV NS by 
Prionics® AG, Switzerland. In addition, samples from impala (n = 21), hartebeest (n = 
7), waterbuck (n = 5), eland (n = 1) and giraffe (n = 1) were tested in the same way. 
Serotype-specific Solid Phase Blocking ELISA (SPBE)  
137 African buffalo serum samples, of which seven were not tested for antibodies 
against NSP, were screened (dilution 1:5) for serotype-specific antibodies against 
FMDV using an in-house SPBE system modified from Have and Holm-Jensen [42] 
and described in detail by Balinda et al. [43]. The O, A, C and Asia 1 tests in this 
ELISA system have been used at the National Veterinary Institute, Danish Technical 
University (Lindholm), for many years; they have been validated for cattle and swine 
(ISO/IEC 17025) and used for many other ruminants and Camelidae with good 
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results, and they appear to work well on all species (Alexandersen, unpublished 
results). The SPBE tests for antibodies against the SAT-serotypes were more recent 
and were still undergoing evaluation. Closely related ELISA tests for the SAT-
serotypes have been set up and used under African conditions for detecting antibodies 
against multiple FMDV serotypes and shown to perform well [43, 44].  
For each well, optical density (OD) as a percentage of the mean OD of four wells with 
negative control sera (ODP) was calculated according to the formula: ODP = ((sample 
OD450 − OD620) / (mean of (negative control sera OD450 − OD620)) × 100. Samples 
were considered positive, if ODP was lower than 50% in the antibody tests for O, 
SAT 1, SAT 2 and SAT 3, 45% for A and 35% for C and Asia 1. 
Based on the serological status and availability of sufficient amounts, 37 positive 
samples were selected and titrated (up to dilution 1:640) in the relevant serotype 
specific SPBEs. Titres were expressed as the reciprocal of the highest positive 
dilution.  
Due to limited sample volumes and the smaller number of trips made, serotype 
specific SPBE studies did not include KVNP. 
FMD Virus isolation and antigen ELISA  
The methodology of virus isolation from the OP samples was adopted from the 
standard procedure described by the World Organisation for Animal Health [45]. 
Briefly, 50µl of undiluted sample and a 1:10 dilution of the sample were each 
inoculated into 5 wells of a 96-well microtitre plate with monolayers of primary 
bovine thyroid (BTY) cells and 100µl of Eagles media with 2% fetal calf serum. A 
row of wells with negative control sera including buffer was inserted between each 
sample. The cell cultures were incubated at 37°C and examined for cytopathic effect 
(CPE) for 2-4 days. Negative cultures were passaged onto new bovine thyroid (BTY) 
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monolayers once. First and second passage cultures with CPE were harvested and 
serotyped using an in-house antigen ELISA set up at the National Veterinary Institute, 
Lindholm, Denmark, based on the description by OIE [45]. Briefly, the rabbit and 
guinea pig hyperimmune sera were the same as used in the in-house SPBE for 
serotype-specific antibodies against FMDV described above. The samples were tested 
in duplicate, and for each serotype each plate included two wells with strong positive 
control sera, two wells with weak positive control sera and two wells with negative 
control sera, all consisting of cell-culture materials. The tests for serotypes O, A, C 
and Asia 1 were quality assured (ISO/IEC 17025), while the tests for serotypes SAT 
1, SAT 2 and SAT 3 were more recently set up and still undergoing evaluation. 
RNA extraction, RT-PCR and cycle sequencing 
Total RNA was extracted from CPE positive cell cultures using the RNeasy-Mini 
Kit® (Qiagen, Germany) according to the manufacturer’s instructions. cDNA was 
synthesized from the template using Ready-To-Go® You-Prime First-Strand Beads 
(GE Healthcare Life Sciences, UK) and a four-primer mix of NVT24 , A PN 63 (5´- 
AGACCTGGAAAGACCAGGC-3’), G15H , and pdN6 (random hexamers). To 
generate 15 overlapping PCR fragments for near full length genome sequencing, 15 
PCR-tubes were prepared containing: 33.1 µl of water, 5.0 µl 5 X AmpliTaq Gold 
buffer, 4.0 µl MgCl2 (25mM), 0.4 µl dNTPs (2.5 mM each), 2.5 Units of Amplitaq 
Gold® (Applied Biosystems, UK) and 5.0 µl of template cDNA. To each of these 
tubes, 1.0 µl of respective fragment-specific forward and reverse primers, each at a 
concentration of 25 pmol/µl was added to make a total volume of 50 µl. 
The primers used for the VP1 coding region are shown in Table 3. The PCR (Perkin 
Elmer PE 9700) was set and ran at 95°C for 5 minutes to activate Amplitaq enzyme 
followed by five cycles (95°C for 15 seconds, 55°C for 30 seconds with less by 1 
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second in each subsequent cycle and then 72°C for 1 minute and 20 seconds), 40 
cycles (95°C for 15 seconds, 50°C for 30 seconds, and 72°C for 1 minute and 20 
seconds–adding 1 second per cycle) and lastly at 72 °C for 7 minutes and kept at 4°C. 
To confirm the presence or absence of PCR products, gel electrophoresis was 
undertaken using 1.2% agarose containing 0.005% ethidium bromide. Amplicons 
were extracted from the gel using the Qiaquick® (Qiagen, Germany) gel extraction kit 
and sent to AGOWA (Germany) for cycle sequencing.  
Sequence analysis 
A phylogenetic tree of the virus sequences was inferred using the Neighbor-Joining 
method [46]. The bootstrap consensus tree inferred from 1000 replicates is taken to 
represent the evolutionary history of the taxa analyzed [47]. The evolutionary 
distances were computed using the Kimura 2-parameter method [48] and are in the 
units of the number of base substitutions per site. The sequences studied were all from 
the VP1 coding region of the current FMDV isolates and the reference topotypes 
(Table 4). All positions containing gaps and missing data were eliminated from the 
dataset. There were a total of 660 nucleotides in the final dataset. Phylogenetic 
analyses were conducted in MEGA 4 [49, 50]. In order to deduce the amino acid 
sequences, the East African SAT 2 prototype sequences together with the Ugandan 
buffalo sequences (this study) and those from cattle during 2004 [26] corresponding 
to the C-terminal part of the VP1, were aligned and translated in MEGA 4 and 
exported to the Bioedit sequence alignment editor [51] to identify the positions of 
differences and similarities.  
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Figures 
Figure 1 - Neighbour-joining tree depicting VP1 coding sequence relationships 
of the recent Ugandan SAT 1 isolate (SAT 1/UGA/07) with other SAT 1 reference 
prototypes from WRLFMD, Pirbright  
Bootstrap values ≥ 50, based on 1,000 replicates are indicated next to the relevant 
node. 
Figure 2 - Neighbour-joining tree depicting VP1 coding sequence relationships 
of the recent Ugandan SAT 2 isolates (SAT 2/UGA/1/07 and SAT 2/UGA/2/07) 
with other SAT 2 reference prototypes from WRLFMD, Pirbright 
Bootstrap values ≥ 50, based on 1,000 replicates are indicated next to the relevant 
node. 
Figure 3 - An alignment of the seventeen deduced amino acid sequences of the 
C-terminal region of VP1 from the East African SAT 2 FMD reference prototype 
virus strains and those collected from livestock and African buffalos in 
Uganda, between the years 2004 and 2007 
Dots indicate sequence identity with master sequence, UGA/1/07 while the “?” in the 
ZAI/1/82 sequence denotes an ambiguity. The highly conserved 'RGD' cell 
attachment motifs are indicated by the shaded text box at positions 144-146. The 
recent buffalo sequences (UGA/1/07) and (UGA/2/07) have a number of amino acid 
differences from the other SAT 2 sequences including those from cattle in Uganda. 
These are clustered particularly within the regions 135-160 (G-H loop) and near the 
extreme C-terminus (residues 190-205). Such differences may be important in 
influencing the antigenicity of these various strains.  
Figure 4 - Map of Uganda showing the location of the National Parks  
NP stands for the National Park. 
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Tables 
Table 1 - Screening of serum samples from wildlife collected in four Ugandan 
National Parks during 2005-2008 for antibodies against the non-structural 
proteins of foot-and-mouth disease virus 
National 
Park 
Species Total 
samples 
collected 
Number of 
samples tested 
Number of 
positive 
samples 
MFNP Buffalo  53 53 51 (96%) 
  
Waterbuck 5 5 0 (0%) 
  
Hartebeest 7 7 1 (14%) 
  
Giraffe 1 1 0 (0%) 
LMNP Buffalo  25 19 18 (95%) 
  
Impala 21 21 0 (0%) 
  
Eland 1 1 0 (0%) 
KVNP Buffalo  42 42 26 (62%) 
QENP Buffalo  94 93 81 (87%) 
  
Total buffalo 214 207 176 (85%) 
  
Total other 
species 
35 35 1 (3%) 
Total   249 242 177 
(MFNP-Murchison Falls National Park, LMNP-Lake Mburo National Park, KVNP-
Kidepo Valley National Park, QENP-Queen Elizabeth National Park). 
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Table 2 - Titres of serotype-specific antibodies against foot-and-mouth disease 
virus in serum samples from African buffalos collected in three National Parks 
in Uganda during 2005-2008 
National 
Park 
Sample 
ID 
Date  O SAT 1 SAT 2 SAT 3 
LMNP BUF 3 JAN.06 − − 20 − 
 
BUF 2 JAN.06 10 20 80 − 
 
BUF 7 JAN.06 − − 640 10 
 
BUF 1 JAN.07 20 320 20 − 
 
BUF 6 JAN.07 20 40 20 5 
 
BUF 10 APR.07 160 640 80 640 
 
BUF 9 APR.07 40 80 80 40 
 
BUF 11 APR.07 10 20 40 40 
 
BUF 12 APR.07 − 160 − 5 
 
BUF 6 APR.07 − − 40 − 
 
BUF 1 OCT.08 − 640 − 80 
 
BUF 4 OCT.08 − 80 40 20 
 
BUF 5 OCT.08 − 80 − − 
 
BUF 6 OCT.08 − 80 20 20 
MFNP BUF 2 OCT.05 160 320 80 160 
 
BUF 7 OCT.05 5 320 160 320 
 
BUF 15 OCT.05 320 640 160 160 
 
BUF 2 NOV.06 5 10 320 20 
 
BUF 3 NOV.06 20 80 40 80 
 
BUF 7 NOV.06 40 80 10 80 
 
BUF 12 OCT.07 40 80 160 160 
 
BUF 5 OCT.07 20 20 20 160 
 
BUF 20 OCT.07 40 640 40 320 
 
BUF 18 OCT.07 640 640 320 320 
QENP BUF 17 JAN.07 5 160 80 20 
 
BUF 37 APR.07 5 20 40 20 
 
BUF 35 APR.07 − − 320 40 
 
BUF 8 JUL.07 80 320 160 40 
 
BUF 9 AUG.07 20 320 320 160 
 
BUF 3 AUG.07 160 640 80 320 
 
BUF 13 AUG.07 80 640 80 160 
 
BUF 1 OCT.08 5 − 40 160 
 
BUF 2 OCT.08 40 640 40 80 
 
BUF 3 OCT.08 10 80 320 20 
 
BUF 5 OCT.08 − − 80 40 
 
BUF 6 OCT.08 10 − − − 
 
BUF 9 OCT.08 40 − − − 
Total      7/27 
(26%) 
23/29 
(79%) 
18/32 
(56%) 
16/30 
(53%) 
Minus signs (−): results of samples with titres < 5 in the screening test and thus not 
titrated. 
Bold figures: results of samples tested positive (ODP ≥ 80) 
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Table 3. List of primers used for RT-PCR. For each fragment, forward and 
reverse primers were used 
Sample 
ID 
Forward Primers (5´ to 3´) Reverse primers (5´ to 3´) 
BUF 10  CAGTACTCCGGCAGCCTG GGTGTTGTAATTGCACTCTCC 
 CAGTGGTGTTCTCGCACAAC GCCATDGGMGGGATGAACCC 
BUF 6 GACCGTATTCTCACCACGAG AAGTTGGACCTGACGTCGG 
BUF 17 CAAAXAGGGAATTTTXCCCGTXGC  GACGACXGGXTTGTCGCC 
 CTGGTXGGCGCAATCCTXCGT CGGTTRAAGTCGGGWCCGTG 
The sequences obtained from samples BUF 10, BUF 6 and BUF 17 were 
subsequently named SAT 2/UGA/1/07, SAT 2/UGA/2/07 and SAT 1/UGA/1/07, 
respectively. These samples were all collected on the same day (17/1/07) in Queen 
Elizabeth National Park, but BUF 17 was from a different herd. 
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Table 4. Summary of the Viruses used in this study 
Serotype Host Animal Virus strain GenBank accession no. Country 
SAT 1 Buffalo SAT1/UGA/1/07* HM067706  Uganda 
 − SAT1/T155/71* N/A Tanzania 
 − SAT1/ZIM/23/2003 N/A Zimbabwe 
 − SAT1/RV/11/37 AY593839 Unknown 
 − SAT1/RHO/5/66 AY593846 Rhodesia 
 − SAT1/BEC/1/48 AY593838 Botswana 
 − SAT1/BOT/1/68 AY593845 Botswana 
 Buffalo SAT1/UGABUFF/21/70 N/A Uganda 
 − SAT1/NIG/11/75 AF431711 Nigeria 
 − SAT1/ISR/4/62 AY593844 Israel 
 − SAT1/SUD/3/76 AY441996 Sudan 
 − SAT1/UGA/13/74 AY442010 Uganda 
 − SAT1/UGA/1/97* AY442012 Uganda 
 Cattle SAT1/ETH/3/2007 FJ798154 Ethiopia 
SAT 2 Cattle SAT2/UGA/01/2004* GU323171 Uganda 
 Cattle SAT2/UGA/05/2004* GU323174 Uganda 
 Cattle SAT2/UGA/12/2004* GU323179 Uganda 
 Buffalo SAT2/UGA/1/2007* HM067705 Uganda 
 Buffalo SAT2/UGA/2/2007* HM067704 Uganda 
 − SAT2/SA/106/59 AY593848 Unknown 
 − SAT2/ZIM/14/2002 N/A Zimbabwe 
 Cattle SAT2/ZIM/7/83* AF136607 Zimbabwe 
 − SAT2/ZIM/5/81 EF134951 Zimbabwe 
 − SAT2/RHO/1/48 AY593847 Rhodesia 
 Buffalo SAT2/ BOT/P3/98 AF367124 Botswana 
 Cattle SAT2/KEN/1/84 AY344505 Kenya 
 Cattle SAT2/ETH/1/90 AY343935 Ethiopia 
 Cattle SAT2/NIG/2/75 AF367139 Nigeria 
 Cattle SAT2/GHA/2/90 AF479415 Ghana 
 Cattle SAT2/GAM/8/79 AF479410 Gambia 
 Cattle SAT2/SAU/6/2000 AF367135 Saudi Arabia 
 − SAT2/CAR/8/2005 N/A Cameroon 
 − SAT2/ZAI/1/74 DQ009737 DRC 
 Cattle SAT2/RWA/1/00* AF367134 Rwanda 
 Cattle SAT2/KEN/3/57 AJ251473 Kenya 
 Cattle SAT2/KEN/2/84 AY343941 Kenya 
 − SAT2/ZAI/1/82 AF367100 Zaire 
 Cattle SAT2/UGA/19/98 AY343969 Uganda 
 − SAT2/ANG/4/74 AF479417 Angola 
 Cattle SAT2/UGA/51/75 AY343963 Uganda 
 Cattle SAT2/SUD/6/77 AY343939 Sudan 
 Cattle SAT2/ETH/2/2007 FJ798161 Ethiopia 
 Cattle SAT2/ETH/2/91 AY343938 Ethiopia 
  *: not WRLFMD reference numbers 
  −: host animal not indicated 
 NA: not applicable 
Figure 1
Figure 2
Figure 3
Figure 4
